MGNX
MacroGenicsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
MGNX vs peer average
85/100
MGNX vs. peer average (A vs. C)
Grade spread
A 3 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ALXO is the first available peer comparator.
ALX Oncology is retained only as a loose same-sector, similar-market-cap oncology development comparator from the packet. It can help frame clinical-event volatility and cash-runway sensitivity, but it is not a direct operating or modality peer for MacroGenics' ADC-focused pipeline.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MGNX
MacroGenics
ALXO
ALX Oncology
Grade
A
F
Momentum
96
29
Value
41
41
Sentiment
53
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ALXO
MGNX / ALXO
Grade Position
Above peers
MGNX vs. peer average (A vs. C)
85/100
Momentum
96
MGNXValue
41
MGNXSentiment
53
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MGNX
ALXO is the first peer returned for this comparison set.